Asthika Goonewardene

Shares of cell therapy company Legend Biotech Corp (NASDAQ:LEGN) were trading lower on Monday, after being among the top pharma gainers in the first week of June. The company's Carvykti drug is likely to return to growth and revive investor enthusiasm, according to Truist Securities. The Legend...

Pfizer (NYSE: PFE) continues to pursue AstraZeneca plc (NYSE: AZN) despite three rejections this year and grave concern by U.K. politicians. History Of Bids On May 1, 2014, Bloomberg reported that Pfizer could raise its bid for AstraZeneca to more than $106 billion (63 billion pounds) and...